Peter Hau
Researcher Next ID · RN-000070
Professor · Computer Science
University Hospital Regensburg
Regensburg, Germany
- Works count
- 425
- Citation count
- 30,022
- H-index
- 57
- i10-index
- 157
About
425 publications and 30,014 citations recorded on OpenAlex.
Research interests
Publications
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
The Lancet Oncology · 2017 · 10.1016/s1470-2045(17)30517-x
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70379-1
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
The Lancet Oncology · 2009 · 10.1016/s1470-2045(09)70025-7
CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles
Cancer Research · 2007 · 10.1158/0008-5472.can-06-4180
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
New England Journal of Medicine · 2005 · 10.1056/nejmoa043331
Current projects
No projects listed.